RELMADA THERAPEUTICS, INC. (RLMD)
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Relmada Therapeutics, Inc.
NASDAQ:RLMDHealthcare · Biotechnology
+4.07%$3.58
AH$3.50-2.23%vs close
Mkt Cap$381.88M
Float86.94M
O/S106.67M
Vol
$ Vol
RVOL
Inst Own94.2%
SI14.0%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$57.39M
Total Assets$94M
Free Cash Flow-$45.79M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$86.51M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
- 1:4Reverse splitSep 30, 20194 shares → 1
- 1:5Reverse splitAug 12, 20155 shares → 1
Balance Sheet Details
Assets$94M
Liabilities$7.49M
Accounts Receivable$0
Accounts Payable$1.57M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2013-08-31 | 2012-08-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5K | $8K |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | -35.4% | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5K | $3K | $85K | $55K | $9K | $4K | $6K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5K | -$3K | -$85K | -$55K | -$9K | $1K | $2K |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | 21.3% | 27.0% |
| Research and Development | $745K | $46.18M | $54.81M | $113.32M | $90.62M | $35.97M | $7.86M | $7.03M | $2.94M | $1.29M | $6.21M | $7.87M | $0 | $0 |
| Selling, General, and Administrative | $312K | $37.72M | $48.9M | $47.93M | $35.08M | $24.87M | $7.25M | $5.7M | $3.98M | $5.71M | $9.88M | $9.23M | $46K | $14K |
| Other | $58.04M | $0 | $0 | $923 | $0 | $0 | $0 | $0 | $2K | $0 | $130K | $0 | $0 | $0 |
| Total Operating Expenses | $59.1M | $83.89M | $103.7M | $161.25M | $125.7M | $60.84M | $15.11M | $12.73M | $6.92M | $7.22M | $16.22M | $17.1M | $46K | $14K |
| Operating Income (EBIT) | -$59.1M | -$83.89M | -$103.7M | -$161.25M | -$125.7M | -$60.84M | -$15.11M | -$12.73M | -$6.92M | -$7.22M | -$16.22M | -$17.1M | -$45K | -$12K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | -877.7% | -151.8% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.34M | $550 | $0 | $5K | $0 | $0 |
| Interest Income | $1.4M | $3.53M | $5.15M | $2.66M | $1.2M | $1.4M | $104 | -$761K | $0 | $0 | $2K | $11K | $0 | $0 |
| Other Income (Expense) | $1.72M | $3.91M | $4.91M | $4.21M | -$48K | $1.38M | $104K | -$5.7M | -$2.04M | $932K | $13.24M | -$3.7M | $0 | $0 |
| Income Before Tax (EBT) | -$57.39M | -$79.98M | -$98.79M | -$157.04M | -$125.75M | -$59.46M | -$15.01M | -$17.32M | -$8.96M | -$6.29M | -$2.98M | -$20.8M | -$45K | -$12K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.59M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$57.39M | -$79.98M | -$98.79M | -$157.04M | -$125.75M | -$59.46M | -$15.01M | -$17.32M | -$8.96M | -$6.29M | -$2.98M | -$20.8M | -$45K | -$12K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | -877.7% | -151.8% |
| Supplementary Data | ||||||||||||||
| EPS | -1.45 | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 | -1.63 | -2.74 | -2.86 | -2.08 | -1.03 | -8.37 | -0.03 | -0.01 |
| Diluted EPS | -1.45 | -2.65 | -3.28 | -5.30 | -7.16 | -3.81 | -1.63 | -2.74 | -2.86 | -2.08 | -1.03 | -8.37 | -0.03 | -0.01 |
| Weighted Average OS | 39.48M | 30.16M | 30.10M | 29.63M | 17.55M | 15.59M | 9.23M | 6.31M | 3.14M | 3.02M | 2.90M | 2.48M | 24.33M | 3.15M |
| EBITDA | -$57.39M | -$79.98M | $4.91M | -$157.04M | -$125.75M | -$59.33M | -$15.1M | -$16.55M | -$6.92M | -$6.92M | -$16.03M | -$17.09M | -$45K | -$12K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | -872.8% | -147.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2012-08-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $3.5M | $3.86M | $4.09M | $5.4M | $44.44M | $2.5M | $36.28M | $9.22M | $2.24M | $1.71M | $8.5M | $22.47M | $25.56M | $9K |
| Short-Term Investments | $89.51M | $41.05M | $92.23M | $142.93M | $167.47M | $114.6M | $80.16M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $93.01M | $44.91M | $96.32M | $148.32M | $211.91M | $117.09M | $116.44M | $9.22M | $2.24M | $1.71M | $8.5M | $22.47M | $25.56M | $9K |
| Accounts Receivable | $0 | $0 | $0 | $512K | $86K | $79K | $73K | $247K | $72K | $292K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $459K | $427K | $473K | $535K | $1.35M | $0 | $6K |
| Other Current Assets | $0 | $0 | $0 | $0 | $35 | -$10 | $46 | $0 | $0 | $125K | $232K | $710K | $0 | $3K |
| Total Current Assets | $93.98M | $45.8M | $97.51M | $152.87M | $223.3M | $118.07M | $116.94M | $9.98M | $2.74M | $2.47M | $9.3M | $23.97M | $25.74M | $18K |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $1K | $5K | $7K | $12K | $2K | $531K | $24K | $10K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $203K | $273K | $338K | $391K | $391K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $20K | $22K | $43K | $35K | $28K | $111K | $191K | $25K | $25K | $22K | $24K | $10K | $12K | $0 |
| Total Long-Term Assets | $20K | $22K | $43K | $35K | $28K | $113K | $196K | $235K | $310K | $362K | $946K | $425K | $22K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $94M | $45.82M | $97.55M | $152.91M | $223.33M | $118.19M | $117.14M | $10.22M | $3.05M | $2.84M | $10.24M | $24.39M | $25.76M | $18K |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $1.57M | $4.13M | $3.51M | $5.26M | $11.19M | $8.35M | $523K | $924K | $765K | $530K | $1.26M | $835K | $746K | $7K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $110K | $364K | $285K | $277K | $274K | $264K | $58K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.32M | $660K | $395K | $635K | $482K | $382K | $0 |
| Other Current Liabilities | $535K | $1.15M | $5.68M | $1.02M | $1.64M | $1.8M | $250K | -$45 | $4.81M | $514K | $893K | $14M | $25.59M | $0 |
| Total Current Liabilities | $6.43M | $10.29M | $12.19M | $12.47M | $15.06M | $12.6M | $1.46M | $2.61M | $5.9M | $1.38M | $3.06M | $15.58M | $26.77M | $7K |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.66M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $91K | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.06M | $4K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $141K | $0 | $100K | $0 |
| Total Long-Term Liabilities | $1.06M | $4K | $0 | $0 | $0 | $0 | $0 | $0 | $2.66M | $0 | $141K | $0 | $100K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.49M | $10.3M | $12.19M | $12.47M | $15.06M | $12.6M | $1.46M | $2.61M | $8.56M | $1.38M | $3.2M | $15.58M | $26.87M | $7K |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 | $72 | $3K | $0 |
| Common Stock | $73K | $30K | $30K | $30K | $28K | $16K | $14K | $10K | $3K | $13K | $12K | $11K | $40K | $24K |
| Retained Earnings | -$698.27M | -$640.88M | -$560.9M | -$462.11M | -$305.07M | -$179.32M | -$119.86M | -$111.66M | -$94.34M | -$85.38M | -$79.1M | -$76.12M | -$55.32M | -$12K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $784.71M | $676.37M | $646.23M | $602.52M | $513.3M | $284.88M | $235.52M | $119.27M | $88.83M | $86.83M | $86.13M | $84.92M | $3K | $0 |
| Total Equity | $86.51M | $35.52M | $85.36M | $140.44M | $208.26M | $105.58M | $115.68M | $7.61M | -$5.51M | $1.46M | $7.04M | $8.81M | -$55.28M | $11K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $94M | $45.82M | $97.55M | $152.91M | $223.33M | $118.19M | $117.14M | $10.22M | $3.05M | $2.84M | $10.24M | $24.39M | -$28.4M | $18K |
| Supplementary Data | ||||||||||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $0 | $110K | $364K | $2.94M | $277K | $274K | $264K | $58K | $0 |
| Net Debt | -$3.5M | -$3.86M | -$4.09M | -$5.4M | -$44.44M | -$2.5M | -$36.17M | -$8.85M | $703K | -$1.43M | -$8.23M | -$22.21M | -$25.51M | -$9K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2013-08-31 | 2012-08-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$57.39M | -$79.98M | -$98.79M | -$157.04M | -$125.75M | -$59.46M | -$15K | -$17.32M | -$8.96M | -$6.29M | -$2.97M | -$20.8M | -$45K | -$12K |
| Depreciation & Amortization | $0 | $0 | $103.7M | $2K | $1K | $4K | $4K | $5K | $3K | $85K | $55K | $9K | $250 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.83M | $709K | -$620K | -$13.31M | $3.71M | $0 | $0 |
| Stock-Based Compensation | $14.96M | $30.19M | $43.81M | $44.19M | $40.49M | $20.78M | $3K | $1.21M | $518K | $704K | $1.21M | $797K | $14K | $0 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $512K | -$426K | $79K | $73K | $0 | -$169K | $225K | -$655 | -$232 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $169K | $0 | $0 | $0 | $0 | $3K | $491 |
| Accounts Payable | -$2.56M | $625K | -$1.76M | $421K | $2.85M | $7.82M | $0 | $159K | $157K | -$730K | $424K | $89K | $27K | $7K |
| Other Working Capital | -$1.39M | -$2.21M | $4.32M | $10.6M | -$10.79M | $2.95M | -$26 | $1.35M | $543K | $482K | $1.25M | -$1.21M | $3K | -$3K |
| Total Working Capital Change | -$3.95M | -$1.58M | $3.08M | $10.59M | -$7.86M | $10.85M | -$26 | $1.51M | $700K | -$248K | $1.68M | -$1.12M | $33K | $4K |
| Other Non-Cash Items | $586K | -$382K | -$103.46M | -$1.55M | $1.25M | $17K | -$4K | $267K | $1.03M | -$722K | -$13.11M | $4.89M | -$14K | $0 |
| Net Cash from Operating | -$45.79M | -$51.76M | -$51.66M | -$103.8M | -$91.87M | -$27.81M | -$12K | -$10.5M | -$6M | -$6.47M | -$13.14M | -$16.23M | -$12K | -$8K |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$12K | -$50K | -$562K | -$23K | -$2K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$83.83M | -$12.08M | -$90.46M | -$47.29M | -$222.98M | -$182.05M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $35.69M | $63.64M | $140.92M | $67.03M | $168.86M | $147.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | -$80K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$48.14M | $51.56M | $50.45M | $19.73M | -$54.12M | -$34.45M | -$80K | $0 | -$12K | -$50K | -$562K | -$23K | -$2K | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | - | - | - | $110K | - | $285K | -$6.53M | $274K | $264K | $294K | - | - |
| Common Stock Issuance | $93.64M | $247K | $0 | $42.73M | $185.31M | $20.53M | $0 | $17.76M | $0 | $0 | $0 | $13.45M | $20K | $14K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$73K | -$287K | -$98K | $2.29M | $2.63M | $8.06M | $126K | $0 | $0 | $0 | $0 | $13.45M | $0 | $0 |
| Net Cash from Financing | $93.56M | -$40K | -$98K | $45.02M | $187.94M | $28.47M | $126K | $17.48M | $6.54M | -$274K | -$264K | $13.16M | $20K | $14K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | -$27K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$360K | -$235K | -$1.3M | -$39.05M | $41.95M | -$33.78M | $7K | $6.98M | $528K | -$6.79M | -$13.97M | -$3.09M | $6K | $6K |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$45.79M | -$51.76M | -$51.66M | -$103.8M | -$91.87M | -$27.81M | -$12K | -$10.5M | -$6M | -$6.47M | -$13.14M | -$16.23M | -$12K | -$8K |
| Capital Expenditure | $0 | $0 | -$4 | $0 | $0 | $0 | $0 | $0 | -$12K | -$50K | -$562K | -$23K | -$2K | $0 |
| Free Cash Flow | -$45.79M | -$51.76M | -$51.66M | -$103.8M | -$91.87M | -$27.81M | -$12K | -$10.5M | -$6.01M | -$6.52M | -$13.71M | -$16.25M | -$14K | -$8K |
| Cash at Beginning | $3.86M | $4.09M | $5.4M | $44.44M | $2.5M | $36.28M | $2K | $2.24M | $1.71M | $8.5M | $22.47M | $25.56M | $9K | $3K |
| Cash at End | $3.5M | $3.86M | $4.09M | $5.4M | $44.44M | $2.5M | $9K | $9.22M | $2.24M | $1.71M | $8.5M | $22.47M | $15K | $9K |